Peginterferon alfa-2a biosimilar (PanPharmaceuticals)

聚乙二醇化干扰素α2a生物类似药 (PanPharmaceuticals)

Report date: 2022/02/09 09:45:32

Base Information

Drug NamePeginterferon alfa-2a biosimilar (PanPharmaceuticals)
Drug Alias Name聚乙二醇化干扰素α2a生物仿制药 (PanPharmaceuticals)
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsHepatitis C
Approved Indications in ChinaN/A
Original Approved Country/TerritoryPakistan
Original Approved Date2011/12/01
Country/TerritoryPakistan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPanpharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesPanpharmaceuticals
Inactive CompaniesN/A
Active IndicationsHepatitis C
Inactive IndicationsN/A

Other Information

ATC CodeL03AB11
Related LinksN/A